Literature DB >> 13546550

The absorption of Clostridium botulinum type A toxin from the alimentary canal.

A J MAY, B C WHALER.   

Abstract

Entities:  

Keywords:  CLOSTRIDIUM BOTULINUM; GASTROINTESTINAL SYSTEM/physiology

Mesh：

Substances：

Year:  1958        PMID： 13546550      PMCID： PMC2082215     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN： 0007-1021


× No keyword cloud information.
  6 in total

1.  Botulinum type A toxin: properties of a toxic dissociation product.

Authors:  J WAGMAN; J B BATEMAN
Journal:  Arch Biochem Biophys       Date:  1953-08       Impact factor: 4.013

2.  Botulism in the mouse, mink, and ferret with special reference to susceptibility and pathological alterations.

Authors:  T MOLL; C A BRANDLY
Journal:  Am J Vet Res       Date:  1951-10       Impact factor: 1.156

3.  Studies on the absorption of proteins: the amino-acid pattern in the portal blood.

Authors:  C E Dent
Journal:  Biochem J       Date:  1949       Impact factor: 3.857

4.  THE ROUTE OF INGESTED EGG WHITE TO THE SYSTEMIC CIRCULATION.

Authors:  H L Alexander; K Shirley; D Allen
Journal:  J Clin Invest       Date:  1936-03       Impact factor: 14.808

5.  Route of absorption of colostrum globulin in the newborn animal.

Authors:  R S COMLINE; H E ROBERTS; D A TITCHEN
Journal:  Nature       Date:  1951-04-07       Impact factor: 49.962

6.  The Purification and Crystallization of Clostridium botulinum Type A Toxin.

Authors:  C Lamanna; O E McElroy; H W Eklund
Journal:  Science       Date:  1946-05-17       Impact factor: 47.728
  6 in total
  14 in total

1.  Influence of nerve-ending activity and of drugs on the rate of paralysis of rat diaphragm preparations by Cl. botulinum type A toxin.

Authors:  R HUGHES; B C WHALER
Journal:  J Physiol       Date:  1962-02       Impact factor: 5.182

2.  Influence of ingested foods on the oral toxicity in mice of crystalline botulinal type A toxin.

Authors:  C LAMANNA; C E MEYERS
Journal:  J Bacteriol       Date:  1960-03       Impact factor: 3.490

3.  ACTIVITY OF TYPE A BOTULINAL TOXIN AND HEMAGGLUTININ EXPOSED TO PROTEOLYTIC ENZYME.

Authors:  E A Meyer; C Lamanna
Journal:  J Bacteriol       Date:  1959-08       Impact factor: 3.490

4.  Pure botulinum neurotoxin is absorbed from the stomach and small intestine and produces peripheral neuromuscular blockade.

Authors:  A B Maksymowych; M Reinhard; C J Malizio; M C Goodnough; E A Johnson; L L Simpson
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

5.  Intestinal absorption of botulinum toxins of different molecular sizes in rats.

Authors:  S Sugii; I Ohishi; G Sakaguchi
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

6.  Biophysical characterization of the stability of the 150-kilodalton botulinum toxin, the nontoxic component, and the 900-kilodalton botulinum toxin complex species.

Authors:  F Chen; G M Kuziemko; R C Stevens
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

7.  Lymph culture: a new tool for the investigation of human infections.

Authors:  W R Cole; M H Witte; C L Witte
Journal:  Ann Surg       Date:  1969-10       Impact factor: 12.969

Review 8.  Status of bacterial toxins and their nomenclature: need for discipline and clarity of expression.

Authors:  P F Bonventre; R E Lincoln; C Lamanna
Journal:  Bacteriol Rev       Date:  1967-06

9.  Botulism in metronidazole- treated conventional adult mice challenged orogastrically with spores of Clostridium botulinum type A or B.

Authors:  Y Wang; H Sugiyama
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

10.  Intraintestinal toxin in infant mice challenged intragastrically with Clostridium botulinum spores.

Authors:  H Sugiyama; D C Mills
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.